MatriSys Announces Positive Results From a Phase I Study of MSB-0221 for the Topical Treatment of Atopic Dermatitis
- Study Reveals the Potential of Beneficial Bacteria to Treat Chronic Skin Diseases - LA JOLLA, Calif., Feb. 22, 2021 (GLOBE NEWSWIRE) -- MatriSys Bioscience, a company harnessing beneficial bacteria to treat inflammatory skin diseases, today announced the …